| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,282,000 | 2,055,000 | 1,684,000 | 1,877,000 | | Cost of Revenue | 1,917,000 | 1,722,000 | 1,439,000 | 1,641,000 | | | Gross Profit | 365,000 | 333,000 | 245,000 | 236,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 122,000 | 90,000 | 89,000 | 112,000 | | Non Recurring | 39,000 |
-
| 1,000 | 48,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 204,000 | 243,000 | 155,000 | 76,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | 1,000 | (2,000) | 3,000 | | Earnings Before Interest And Taxes | 210,000 | 244,000 | 153,000 | 79,000 | | Interest Expense | 66,000 | 62,000 | 61,000 | 70,000 | | Income Before Tax | 144,000 | 182,000 | 92,000 | 9,000 | | Income Tax Expense | 3,000 | 44,000 | 24,000 | (1,000) | | Minority Interest | (90,000) |
-
|
-
| (24,000) | | | | Net Income From Continuing Ops | 51,000 | 139,000 | 63,000 | (14,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 51,000 | 139,000 | 63,000 | (14,000) | | Preferred Stock And Other Adjustments | 57,000 | (34,000) | (23,000) |
-
| | | Net Income Applicable To Common Shares | $108,000 | $105,000 | $40,000 | ($14,000) |
|
1.00% Nasdaq 
Income Statement
